181 related articles for article (PubMed ID: 31697337)
1. Neuroendocrine Tumors-Less Well Known, Often Misunderstood, and Rapidly Growing in Incidence.
Chauhan A; Kohn E; Del Rivero J
JAMA Oncol; 2020 Jan; 6(1):21-22. PubMed ID: 31697337
[No Abstract] [Full Text] [Related]
2. Distribution, incidence, and prognosis in neuroendocrine tumors: a population based study from a cancer registry.
Caldarella A; Crocetti E; Paci E
Pathol Oncol Res; 2011 Sep; 17(3):759-63. PubMed ID: 21476126
[TBL] [Abstract][Full Text] [Related]
3. Clinical Presentation and Diagnosis of Pancreatic Neuroendocrine Tumors.
Anderson CW; Bennett JJ
Surg Oncol Clin N Am; 2016 Apr; 25(2):363-74. PubMed ID: 27013370
[TBL] [Abstract][Full Text] [Related]
4. Primary small intestinal neuroendocrine tumors are highly prevalent and often multiple before metastatic disease develops.
Eriksson J; Norlén O; Ögren M; Garmo H; Ihre-Lundgren C; Hellman P
Scand J Surg; 2021 Mar; 110(1):44-50. PubMed ID: 31587594
[TBL] [Abstract][Full Text] [Related]
5. Peritoneal Metastases from Gastroenteropancreatic Neuroendocrine Tumors.
Frilling A; Clift AK
Ann Surg Oncol; 2017 Nov; 24(12):3466-3468. PubMed ID: 28815440
[No Abstract] [Full Text] [Related]
6. [Diagnosis and treatment of the neuroendocrine tumors of the lung].
Gálffy G
Magy Onkol; 2018 Jul; 62(2):113-118. PubMed ID: 30027939
[TBL] [Abstract][Full Text] [Related]
7. Pancreatic neuroendocrine tumors: a review.
Young K; Iyer R; Morganstein D; Chau I; Cunningham D; Starling N
Future Oncol; 2015; 11(5):853-64. PubMed ID: 25757686
[TBL] [Abstract][Full Text] [Related]
8. Preliminary results of a Japanese nationwide survey of neuroendocrine gastrointestinal tumors.
Ito T; Tanaka M; Sasano H; Osamura YR; Sasaki I; Kimura W; Takano K; Obara T; Ishibashi M; Nakao K; Doi R; Shimatsu A; Nishida T; Komoto I; Hirata Y; Imamura M; Kawabe K; Nakamura K;
J Gastroenterol; 2007 Jun; 42(6):497-500. PubMed ID: 17671766
[TBL] [Abstract][Full Text] [Related]
9. [Registry of neuroendocrine tumors (NET) in Czech Republic after three years of data collection].
Vítek P; Strenková J; Sedláčková E; Barkmanová J; Mužík J; Louthan O
Klin Onkol; 2013; 26(4):271-80. PubMed ID: 23961858
[TBL] [Abstract][Full Text] [Related]
10. Incidence and Predictors of Second Primary Cancers in Patients With Neuroendocrine Tumors.
Bateni SB; Coburn NG; Law CHL; Singh S; Myrehaug S; Assal A; Hallet J
JAMA Oncol; 2021 Nov; 7(11):1718-1720. PubMed ID: 34591069
[TBL] [Abstract][Full Text] [Related]
11. Paraneoplastic syndromes in neuroendocrine neoplasms of the head and neck: have they an impact on prognosis?
Ferlito A; Shaha AR; Rinaldo A
Acta Otolaryngol; 2001 Sep; 121(6):756-8. PubMed ID: 11678176
[No Abstract] [Full Text] [Related]
12. Pathological incidence of duodenopancreatic neuroendocrine tumors in the Netherlands: a Pathologisch Anatomisch Landelijk Geautomatiseerd Archief study.
Kuiper P; Verspaget HW; van Slooten HJ; Overbeek L; Biemond I; Lamers CB
Pancreas; 2010 Nov; 39(8):1134-9. PubMed ID: 20871479
[TBL] [Abstract][Full Text] [Related]
13. The up-to-date review of epidemiological pancreatic neuroendocrine tumors in Japan.
Ito T; Lee L; Hijioka M; Kawabe K; Kato M; Nakamura K; Ueda K; Ohtsuka T; Igarashi H
J Hepatobiliary Pancreat Sci; 2015 Aug; 22(8):574-7. PubMed ID: 25689058
[TBL] [Abstract][Full Text] [Related]
14. Recent epidemiology of patients with gastro-entero-pancreatic neuroendocrine neoplasms (GEP-NEN) in Japan: a population-based study.
Masui T; Ito T; Komoto I; Uemoto S;
BMC Cancer; 2020 Nov; 20(1):1104. PubMed ID: 33189127
[TBL] [Abstract][Full Text] [Related]
15. Trends and In-Hospital Outcomes of Neuroendocrine Neoplasms.
Desai A; Halfdanarson TR
Pancreas; 2020 Apr; 49(4):e35-e36. PubMed ID: 32282779
[No Abstract] [Full Text] [Related]
16. An updated analysis of the epidemiologic trends of neuroendocrine tumors in Taiwan.
Chang JS; Chen LT; Shan YS; Chu PY; Tsai CR; Tsai HJ
Sci Rep; 2021 Apr; 11(1):7881. PubMed ID: 33846396
[TBL] [Abstract][Full Text] [Related]
17. Pancreatic neuroendocrine neoplasms.
Hörsch D; Bert T; Schrader J; Hommann M; Kaemmerer D; Petrovitch A; Zaknun J; Baum RP
Minerva Gastroenterol Dietol; 2012 Dec; 58(4):401-26. PubMed ID: 23207615
[TBL] [Abstract][Full Text] [Related]
18. The epidemiology of gastroenteropancreatic neuroendocrine tumors.
Lawrence B; Gustafsson BI; Chan A; Svejda B; Kidd M; Modlin IM
Endocrinol Metab Clin North Am; 2011 Mar; 40(1):1-18, vii. PubMed ID: 21349409
[TBL] [Abstract][Full Text] [Related]
19. Neuroendocrine tumors (NETs): historical overview and epidemiology.
Oberg K
Tumori; 2010; 96(5):797-801. PubMed ID: 21302634
[TBL] [Abstract][Full Text] [Related]
20. Localized Well-Differentiated Rectal Neuroendocrine Tumors - Where Are We in 2021?
Amorim LC; Ferreira AR; Perez RO; Peixoto RD
Clin Colorectal Cancer; 2022 Mar; 21(1):e22-e27. PubMed ID: 34838461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
